Ted Slafsky is the President and Chief Executive Officer for Safety Net Hospitals for Pharmaceutical Access (SNHPA), a non-profit organization of over 1,000 hospitals and health systems participating in the federal 340B drug discount program.
Mr. Slafsky oversees a team of government relations experts, attorneys and pharmacists who advocate on behalf of member hospitals and provide guidance on how to utilize the 340B drug discount program. Under Mr. Slafsky's leadership, the organization has grown from 50 member hospitals to nearly 1,000 and SNHPA's staff has increased from just two employees to over 20 staff and consultants.
Mr. Slafsky is also Co-Founder and Editor-in-Chief of the Drug Discount Monitor, the first and only publication to focus specifically on the 340B program. He also oversees SNHPA’s other communications resources including the members only electronic news service, the SNHPA Member Bulletin. Mr. Slafsky is frequently quoted in news publications and is considered one of the nation’s leading experts on pharmaceutical and safety net health care matters.
In addition to his focus on advocacy, communications and member services, Mr. Slafsky is responsible for overseeing a number of conferences and meetings on improving access to pharmaceutical care and ensuring compliance with drug pricing laws.
Before his work with SNHPA, Mr. Slafsky was a reporter and researcher at U.S. News and World Report, where he provided editorial assistance to David Gergen, the magazine’s Editor-at-Large and an advisor to four U.S. presidents. Mr. Slafsky also wrote and researched articles on health, education and other policy areas. He was also a health policy fellow in the United States Senate.
Mr. Slafsky received a Bachelor of Political Science degree from Tufts University magna cum laude and a Master of Public Policy degree from Duke University.
I was disappointed to see Howard Dean's recent blog post criticizing a vital but largely unknown federal drug discount program called 340B. Dean may be a doctor and a gifted former governor, but it's clear he is spending more time on K Street with his drug...